A Warning about Counterfeit Mounjaro, Ozempic, and Other Diabetes Medications

A Warning about Fake Diabetes Medications

Recent shortages of medications like Ozempic and Mounjaro have caused an influx of imitation drugs around the world. The FDA and World Health Organization have issued warnings about the safety risks of taking these counterfeit products because they can contain questionable ingredients that can cause series harm. Dr. Edelman explains how to know if the medication you’re taking is authentic and what to look out for in fake products.

read more

Is This Patient Type 1 or Type 2? The Mystery Continues…

Dr. E's Case Study

Dr. E’s new patient Kyle is a 32-year-old male who was recently diagnosed with type 2 diabetes by his primary care doctor. Kyle has a family history of type 2, but he had one positive autoantibody for type 1, which compelled Dr. E to request more testing. Dr. E shares the latest update, and his treatment plans for Kyle depending on his diagnosis.

read more

CGM Data Goes Hands-Free (But You Still Need a Wrist!) Dexcom’s G7 CGM Now Connects Directly to Apple Watch

Dexcom G7 Now Connects to Apple Watch

Many of us treat our phones like a fifth appendage, but now we can opt to leave our phones at home and still get CGM data. Dexcom recently announced that their G7 CGM can now connect directly to the Apple Watch for users in the U.S, offering people the freedom of real-time glucose readings even when their phone isn’t with them.

read more

An Endocrinologist’s Unique Journey Helping with People Living with Type 1 Diabetes

Dr. Tina Gupta

After seeing the struggles her patients faced living with type 1 diabetes, Dr. Tina Gupta was compelled to do more to help. She left clinical practice and joined Vertex Pharmaceuticals, a company researching treatment therapies that replace non-functioning beta cells with stem-cell- derived cells to try to reduce or eliminate the need for people with T1D to take insulin.

read more

FDA Approves Abbott’s Libre Rio and Lingo Over-the-Counter CGMs

Abbott Libre Rio and Lingo CGMs

The over-the-counter CGM market has two new players…the Lingo and Libre Rio. The two systems created by Abbott were intentionally designed to meet different needs – Lingo for those who want to better understand and improve their health and wellness, and Libre Rio for adults with type 2 diabetes who do not use insulin and typically manage their diabetes through lifestyle modifications.

read more